Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladislav Machala

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Viruses|March 31, 2018
Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ARTAlbert Font-Haro, Vaclav Janovec, Tomas Hofman, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 30, 2016
Steady increase of lymphogranuloma venereum cases, Czech Republic, 2010 to 2015Filip Rob, Kateřina Jůzlová, Helena Krutáková, et al.
Clinical Epigenetics|February 23, 2016
Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individualsKateřina Trejbalová, Denisa Kovářová, Jana Blažková, et al.
Protein Science : a Publication of the Protein Society|June 19, 2008
Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavirKlára Grantz Sasková, Milan Kozísek, Martin Lepsík, et al.
AIDS (London, England)|August 19, 2004
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionAndrew N Phillips, Bruno Ledergerber, Andrezej Horban, et al.
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.
Central European Journal of Public Health|January 18, 2020
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae co-infections among patients with newly diagnosed syphilis: a single-centre, cross-sectional studyFilip Rob, Kateřina Jůzlová, Zuzana Kružicová, et al.
Plos One|February 6, 2014
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in EuropeAlexander Zoufaly, Alessandro Cozzi-Lepri, Joanne Reekie, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infectionJustyna D Kowalska, Amanda Mocroft, Anders Blaxhult, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapyWendy P Bannister, Alessandro Cozzi-Lepri, Jesper Kjær, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Viruses|March 31, 2018
Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ARTAlbert Font-Haro, Vaclav Janovec, Tomas Hofman, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 30, 2016
Steady increase of lymphogranuloma venereum cases, Czech Republic, 2010 to 2015Filip Rob, Kateřina Jůzlová, Helena Krutáková, et al.
Clinical Epigenetics|February 23, 2016
Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individualsKateřina Trejbalová, Denisa Kovářová, Jana Blažková, et al.
Protein Science : a Publication of the Protein Society|June 19, 2008
Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavirKlára Grantz Sasková, Milan Kozísek, Martin Lepsík, et al.
AIDS (London, England)|August 19, 2004
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionAndrew N Phillips, Bruno Ledergerber, Andrezej Horban, et al.
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.
Central European Journal of Public Health|January 18, 2020
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae co-infections among patients with newly diagnosed syphilis: a single-centre, cross-sectional studyFilip Rob, Kateřina Jůzlová, Zuzana Kružicová, et al.
Plos One|February 6, 2014
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in EuropeAlexander Zoufaly, Alessandro Cozzi-Lepri, Joanne Reekie, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infectionJustyna D Kowalska, Amanda Mocroft, Anders Blaxhult, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapyWendy P Bannister, Alessandro Cozzi-Lepri, Jesper Kjær, et al.
Pageof 4